Suloctidil
Suloctidil is a new drug that is currently being evaluated in many clinical trials for use in dementia and thrombotic disorders Target: Effect of suloctidil on Na+/K+ ATPase activity and on membrane fluidity in rat brain synaptosomes.
Product Specifications
CAS Number
[54767-75-8]
UNSPSC
12352005
Hazard Statement
H302
Target
Na+/K+ ATPase
Type
Reference compound
Related Pathways
Membrane Transporter/Ion Channel
Applications
Neuroscience-Neuromodulation
Field of Research
Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/Suloctidil.html
Purity
99.96
Solubility
DMSO : ≥ 30 mg/mL
Smiles
O[C@H]([C@H](NCCCCCCCC)C)C1=CC=C(SC(C)C)C=C1
Molecular Formula
C20H35NOS
Molecular Weight
337.56
Precautions
H302
References & Citations
[1]Chatelain P, et al. Effect of suloctidil on Na+/K+ ATPase activity and on membrane fluidity in rat brain synaptosomes. Biochem Pharmacol. 1979 Dec 15;28 (24) :3677-3680.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
GTR15279435 1 Vial
Lentiviral mouse Slc25a12 shRNA (UAS) - Lentiviral mouse Slc25a12 shRNA (UAS, iRFP) (100)
Ask
View Details